A micro-method has been devised for isolating a lungderived membranous fraction from human amniotic fluid. 
Material derived from lamellar bodies retains a characteristic morphology in the amniotic fluid (4) (5) (6) . Because a significant proportion of lamellar body phospholipid sediments at the low centrifugal forces generally used to remove cell debris from amniotic fluid (C.G. Duck-Chong, unpublished data), isopycnic density centrifugation of whole amniotic fluid (5, 7) represents a better approach to isolating lamellar body-derived material than does differential centrifugation. A micro-method has been devised for isolating a lamellar body fraction from amniotic fluid with a clinical ultracentrifuge
(7).
The phospholipid content of the lamellar body fraction represents a highly variable proportion of the total phospholipid of amniotic fluid, and its contribution to total phospholipid does not simply reflect lung maturity (7 (8) . On collection, each sample of amniotic fluid was divided into two portions. One portion, to be used for the determination of the L/S ratio, was promptly centrifuged at low speed to remove cell debris, then assayed immediately or stored at -20 #{176}C until assay. The remaining, uncentrifuged portion of amniotic fluid was used for the isolation of the lamellar body fraction (7), either on the day of collection or after having been stored frozen. It has been shown that, under these conditions, freezing and thawing the sample once does not significantly affect either LB-PL content (7) or the L/S ratio (9). The LB-PL procedure involved layering four 100-L samples of amniotic fluid over 75 L of a 150 gIL solution of Ficoll 70, then centrifuging at 115 000 X g for 20 mm in a Beckman Airfuge; the lamellar body fraction, which forms a distinct band at the interface between the amniotic fluid and the Ficoll, was collected and its phospholipid content was determined Test procedure (Helena Laboratories, Beaumont, TX 77704) was used, with minor modifications to chromatography solvent and staining technique. Neither of these procedures includes the cold acetone precipitation step recommended by Gluck and Kulovich (3) . In both hospitals, an L/S ratio of 2 or more is accepted clinically as indicating fetal lung maturity.
Diagnoses of respiratory problems were confirmed by roentgenograms of the newborn's chest, assessed by an independent radiologist who was unaware of the clinical condition of the babies. The lungs of all infants diagnosed as suffering from hyalmne membrane disease showed the classical diffuse fine granular pattern on roentgenographic films.
Results and Discussion
The data in this study were derived from pregnancies presenting with a variety of complications (Table 1 ). Figure 1 shows the relation between the LB-PL content of amniotic fluid and gestational age. Mean LB-PL content of amniotic fluid increased with gestational age, a striking feature being (Figure 1 ). An increase in LB-PL from the basal concentration of < 3 mgldL began some time between the 29th and 40th week of gestation, differing among individuals.
Eight cases of hyaline membrane disease, one resulting in death, were encountered in this study. In each, the LB-PL content of the amniotic fluid at the last sampling before delivery was <3.5 mg/dL (Table 2 ). In contrast, for 182 of the 185 pregnancies where amniotic fluid was collected within two days of delivery and where there were no serious respiratory problems, the LB-PL content exceeded 3.5 mg/dL (Figure 2 ). Evidently the achievement of functional lung maturity coincides with the beginning of the increase in LB-PL above the basal level, described above. Respiratory problems other than hyaline membrane disease occurred in another five cases delivered within two days of amniocentesis ( Table 3 ). In two of these cases, the LB-PL content was <3.5 mg/dL. Figure 3 shows a comparison of the L/S ratio and the LB-PL content of amniotic fluid samples collected at Hospital A. Fifty-five per cent of the data are from pregnancies delivered more than two days after sampling and therefore cannot be related to clinical outcome, because there may have been sufficient time for maturation to have occurred after sampling. In 188 of 376 samples, both tests indicated fetal lung maturity, that is, the LB-PL content was >3.5 mg/dL and the L/S ratio was >2. This finding is not surprising in view of the fact that a high proportion of samples were collected after 37 weeks of gestation (Figures 1 and 2) . In another 95 cases, both tests indicated lung immaturity ( Figure 3 ). But in 25% of all cases, the two methods did not agree ( Figure 3) . In 19 cases, mature L/S ratios were associated with immature LB-PL values. Because the L/S ratio incorrectly predicted lung maturity in two of the eight cases of hyaline membrane disease (Table 2) , it is possible that at least some of the data in the latter group represent false L/S ratio predictions; on the other hand, a low LB-PL value was not invariably associated with hyaline membrane disease, as is shown in Figure 2 and Table 3 . In 74 cases, mature LB-PL values were associated with immature L/S ratios ( Figure 3) . The latter group represents 44% of all immature L/S ratios reported. Table 4 shows the clinical outcome in all 17 cases delivered in either hospital shortly after such a finding, apart from those already reported in Table 3 . In 15 cases, there were no respiratory problems; two of the infants developed mild respiratory distress, which resolved within a few hours of delivery. That is, in every case the LB-PL method correctly predicted the outcome, suggesting that most, if not all, of the data in this category represent false predictions of lung immaturity given by the L/S ratio.
Many factors determine the appropriate discriminatory boundary (cut-off value) used to interpret the L/S ratio in a given hospital. For Hospital A (Figure 3 ), altering the cut-off in Hospital A. Because pregnancies delivered shortly after false-immature L/S ratios (Table 4) represent only 5% of all pregnancies in this study, the existence of such a problem would not be readily apparent to the obstetrician. A recent investigation of the L/S ratio, initiated as a result of the findings presented in this paper, has revealed that interference from phosphatidylinositol and (or) phosphatidylserine is probably a factor contributing to the poor performance of the L/S ratio in these trials and in other laboratories, and that including a cold acetone precipitation step in the procedure does not solve the problem (10) .
The micro-procedure for isolating the lamellar body fraction was originally devised with a possible clinical application in mind. A more rapid and sensitive method for determining the phospholipid content of the lamellar body fraction, required to make the whole procedure clinically feasible, is now available (11) . At this early stage, the determination of the LB-PL content of amniotic fluid has proved useful in highlighting the problems with the L/S ratio. Acceptance of the
LB-PL
method as an index of fetal lung maturity in its own right must await the collection of more data in the critical preterm period, before the 35th week of gestation.
